Journal of Commercial Biotechnology — July 2008
The March 2008 issue of the Journal of Commercial Biotechnology is now available. This issue focuses on biotechnology marketing and was guest-edited by Leyland Pitt and Ian McCarthy. The links below will take you to the abstract of each article:
Volume 14, Issue 3
Editorial
| Connecting product innovation management and marketing | |
| Leyland Pitt, Ian McCarthy |
Articles
| New pharmaceutical product development: Barriers to overcome and opportunities to exploit | |
| Nic S Terblanche |
| The biotechnology and marketing interface: Functional integration using mechanistic and holographic responses to environmental turbulence | |
| Pierre Berthon, Leyland Pitt, Deon Nel, Esmail Salehi-Sangari, Anne Engstrom |
| Anticipating and managing the challenges of biotechnology marketing | |
| Heidi Rajamäki |
| A comparison of R&D indicators for the Vancouver biotechnology cluster | |
| Monica Salazar, Martin J Bliemel, J Adam Holbrook |
| Using brand personality to assess whether biotechnology firms are saying the right things to their network | |
| Lisa Papania, Colin Campbell, Robert Ankomah Opoku, Maria Styven, Jean-Paul Berthon |
| Remembering Epimetheus: Biotechnologies and the market | |
| Pierre Berthon, Ekin Pehlivan, Philip DesAutels |
| Networks of dedicated biotechnology and service firms in Vancouver | |
| Martin J Bliemel, Ian P McCarthy |
I want to quote your post in my blog. It can?
And you et an account on Twitter?